GlassScriptPhysician profile
David R Corley
NPI 1689612210
$2,595.78
in general payments reported to CMS, 2019-2025
17 companies · $187 in 2025
The $187 reported for 2025 was more than what a typical Reproductive Endocrinology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $577 · 2020: $354 · 2021: $540 · 2022: $241 · 2023: $385 · 2024: $312 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $884.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $883.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $993.62 | 2019-2025 | Menopur |
| Abbvie INC. | $480.81 | 2019-2023 | Orilissa, Lo Loestrin Fe, Synthroid |
| Organon LLC | $286.57 | 2022-2024 | |
| Emd Serono, INC. | $223.10 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $100.23 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $95.77 | 2023-2025 | Myfembree |
| Coopersurgical, INC. | $83.24 | 2020-2023 | Stripper |
| Teleflex LLC | $75.40 | 2019 | |
| Amag Pharmaceuticals, INC. | $39.93 | 2020 | |
| Dexcom, INC. | $37.06 | 2025 | Dexcom G6 Transmitter |
| Galen US INC | $35.99 | 2019 | |
| Novo Nordisk INC | $30.24 | 2023-2025 | Wegovy, Saxenda |
| Myovant Sciences INC. | $29.31 | 2022 | |
| Amneal Pharmaceuticals LLC | $29.15 | 2024 | Unithroid |
| Pfizer INC. | $27.97 | 2022-2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $15.78 | 2019 | |
| Ibsa Pharma INC. | $11.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Corley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.